share_log

Synopsys, Inc. Just Recorded A 14% EPS Beat: Here's What Analysts Are Forecasting Next

Synopsys, Inc. Just Recorded A 14% EPS Beat: Here's What Analysts Are Forecasting Next

Synopsys, Inc.剛剛錄得14%的每股收益超預期:以下是分析師的預測
Simply Wall St ·  08/23 06:46

Last week saw the newest third-quarter earnings release from Synopsys, Inc. (NASDAQ:SNPS), an important milestone in the company's journey to build a stronger business. Revenues were US$1.5b, approximately in line with expectations, although statutory earnings per share (EPS) performed substantially better. EPS of US$2.61 were also better than expected, beating analyst predictions by 14%. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

上週,新思科技公司(納斯達克股票代碼:SNPS)發佈了最新的第三季度業績,這是該公司建立更強大業務過程中的一個重要里程碑。儘管法定每股收益(EPS)表現要好得多,但收入爲15億美元,大致符合預期。每股收益爲2.61美元,也好於預期,比分析師的預測高出14%。對於投資者來說,這是一個重要時刻,因爲他們可以在報告中追蹤公司的業績,看看專家對明年的預測,看看對該業務的預期是否有任何變化。根據這些結果,我們收集了最新的法定預測,以了解分析師是否改變了盈利模式。

1724409985936
NasdaqGS:SNPS Earnings and Revenue Growth August 23rd 2024
納斯達克GS:SNPS收益和收入增長 2024年8月23日

After the latest results, the 17 analysts covering Synopsys are now predicting revenues of US$6.94b in 2025. If met, this would reflect a modest 7.1% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to step up 10% to US$10.89. Before this earnings report, the analysts had been forecasting revenues of US$6.89b and earnings per share (EPS) of US$10.65 in 2025. So the consensus seems to have become somewhat more optimistic on Synopsys' earnings potential following these results.

根據最新業績,涵蓋新思科技的17位分析師現在預測2025年收入爲69.4億美元。如果得到滿足,這將反映出與過去12個月相比收入略有增長7.1%。預計每股法定收益將增長10%,至10.89美元。在本業績發佈之前,分析師一直預測2025年收入爲68.9億美元,每股收益(EPS)爲10.65美元。因此,在這些業績公佈後,人們對新思科技的盈利潛力的共識似乎變得更加樂觀了。

There's been no major changes to the consensus price target of US$644, suggesting that the improved earnings per share outlook is not enough to have a long-term positive impact on the stock's valuation. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. The most optimistic Synopsys analyst has a price target of US$694 per share, while the most pessimistic values it at US$490. These price targets show that analysts do have some differing views on the business, but the estimates do not vary enough to suggest to us that some are betting on wild success or utter failure.

644美元的共識目標股價沒有重大變化,這表明每股收益前景的改善不足以對股票估值產生長期的積極影響。但是,還有另一種思考價格目標的方法,那就是研究分析師提出的價格目標範圍,因爲範圍廣泛的估計可能表明,對業務可能的結果有不同的看法。最樂觀的新思科技分析師將目標股價定爲每股694美元,而最悲觀的分析師則將其估值爲490美元。這些目標股價表明,分析師對該業務的看法確實有所不同,但這些估計的差異不足以向我們表明,有些人押注取得巨大成功或徹底失敗。

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. We would highlight that Synopsys' revenue growth is expected to slow, with the forecast 5.6% annualised growth rate until the end of 2025 being well below the historical 14% p.a. growth over the last five years. Compare this against other companies (with analyst forecasts) in the industry, which are in aggregate expected to see revenue growth of 12% annually. Factoring in the forecast slowdown in growth, it seems obvious that Synopsys is also expected to grow slower than other industry participants.

現在從大局來看,我們理解這些預測的方法之一是了解它們與過去的業績和行業增長估計相比如何。我們要強調的是,新思科技的收入增長預計將放緩,預計到2025年底的年化增長率爲5.6%,遠低於過去五年14%的歷史年增長率。相比之下,該行業的其他公司(根據分析師的預測),後者的總體收入預計每年將增長12%。考慮到增長放緩的預測,很明顯,新思科技的增長速度預計也將低於其他行業參與者。

The Bottom Line

底線

The most important thing here is that the analysts upgraded their earnings per share estimates, suggesting that there has been a clear increase in optimism towards Synopsys following these results. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. The consensus price target held steady at US$644, with the latest estimates not enough to have an impact on their price targets.

這裏最重要的是,分析師上調了每股收益的預期,這表明在這些業績公佈後,對新思科技的樂觀情緒明顯增強。從好的方面來看,收入估計沒有重大變化;儘管預測表明它們的表現將比整個行業差。共識目標股價穩定在644美元,最新估計不足以對其目標價格產生影響。

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have forecasts for Synopsys going out to 2026, and you can see them free on our platform here.

根據這種思路,我們認爲該業務的長期前景比明年的收益重要得多。我們對新思科技的預測將持續到2026年,你可以在我們的平台上免費查看。

That said, it's still necessary to consider the ever-present spectre of investment risk. We've identified 1 warning sign with Synopsys , and understanding this should be part of your investment process.

儘管如此,仍然有必要考慮永遠存在的投資風險陰影。我們已經向 Synopsys 發現了一個警告信號,我們知道這應該是您投資過程的一部分。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接聯繫我們。或者,也可以發送電子郵件至編輯團隊 (at) simplywallst.com。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論